Search results
Results from the WOW.Com Content Network
Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. Read Next: Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
Sometimes a potential drug or treatment may seem like a failure, but can still be salvaged for researchers' use. That is the case with Vertex Pharmaceuticals Inc.'s (VRTX) VX-864 for Alpha-1 ...
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $228.08, marking a -0.23% move from the previous day.
If you have $500, you should check out Vertex Pharmaceuticals (NASDAQ: VRTX). Here's why this biotech stock is a great candidate to buy and hold forever. First, Vertex's share price currently ...
Get breaking news and the latest headlines on business, ... USA TODAY 15 hours ago ... How major US stock indexes fared Thursday, 12/26/2024. Food.
In 2012 ivacaftor was designated as an orphan drug, identifying cystic fibrosis as affecting fewer than 200,000 people in the United States.On 31 January 2012, Vertex gained FDA approval [22] of the first drug, Kalydeco, [23] to treat the underlying cause of cystic fibrosis rather than the symptoms, in patients 6 years or older who have the G551D gene mutation.
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.23, moving -1.14% from the previous trading session.
VRTX may refer to: Versatile Real-Time ... Vertex Pharmaceuticals (Nasdaq stock symbol) PowerEdge VRTX, a computer hardware product line from Dell This page was last ...